https://studiclinici.aiom.it/studi-clinici/ricerca-studi-clinici/inca33890-101--a-phase-1-open-label-multicenter-study-of-inca33890-in-participants-with-advanced-or-metastatic-solid-tumors/6-511-24464
L'Associazione ha lo scopo di promuovere il progresso oncologico nel campo clinico, sperimentale e socio-assistenziale, la prevenzione primaria e secondaria,...
open labelmulticenter studyphase
https://www.yalemedicine.org/clinical-trials/psma-007-001-study-of-janx007-in-subjects-with-metastatic-castration-resistant-prostate-cancer-eng
This study is a first-in-human, Phase 1, open-label, multicenter study to assess the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and the...
open labelmulticenter studyphase
https://www.prnewswire.com/news-releases/scynexis-inc-announces-first-patient-dosed-in-phase-3-open-label-study-evaluating-oral-ibrexafungerp-in-candida-auris-infections-cares-300730914.html
/PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening...
in phaseincannouncesfirstpatient
https://www.mayo.edu/research/clinical-trials/cls-20391800
Learn more about services at Mayo Clinic.
open label studycisgem
https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2020-0833.html
The Phase 2 monotherapy portion of this study is currently enrolling and will evaluate the efficacy and safety of PC14586 (INN rezatapopt) in participants with...
open labelmulticenter studyphaseassess